Inspiration Healthcare Group Full Year 2025 Earnings: UK£0.19 loss per share (vs UK£0.088 loss in FY 2024)
Revenue: UK£38.3m (up 1.7% from FY 2024).
Net loss: UK£15.0m (loss widened by 148% from FY 2024).
UK£0.19 loss per share (further deteriorated from UK£0.088 loss in FY 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Medical Equipment industry in the United Kingdom.
Performance of the British Medical Equipment industry.
The company's share price is broadly unchanged from a week ago.
You still need to take note of risks, for example - Inspiration Healthcare Group has 4 warning signs (and 3 which are potentially serious) we think you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Child and two adults killed in M5 crash as road remains closed
A teenager and two adults have been killed in a crash on the M5 as another child fights for their life in hospital. Avon and Somerset Police said the teenager and two adults died following the single-vehicle collision involving a BMW car in south Gloucestershire on Friday evening. The second child was rushed to hospital in a critical condition after suffering serious injuries in the incident. The motorway remained closed in both directions between junctions 14 and 13 on Saturday morning. A police statement said: 'A white BMW car left the northbound carriageway at approximately 9pm last night (Friday May 30) between junction 14 (Falfield) and the Michaelwood services. As a result, the M5 remains closed in both directions between junctions 14 and 13 (Stroud). 'We're sad to report two adults in their 40s and one teenage child who were travelling in the vehicle have died from their injuries. 'A second child sustained serious injuries and they have been taken to hospital where they remain in a critical condition.'
Yahoo
41 minutes ago
- Yahoo
The importance of regular eye exams
The number of people experiencing vision loss in Alberta is on the rise. While there can be various reasons for this decline, preventative care is often crucial. Our interview features Dr. Shaminder Dhaliwal, an Edmonton-based optometrist and the owner of Prairie Eye Care, who will discuss this important topic.
Yahoo
41 minutes ago
- Yahoo
Billionaires Are Buying 2 Artificial Intelligence (AI) Stocks That Wall Street Analysts Say Can Soar Up to 240%
Several billionaire hedge fund managers bought shares of Palantir and/or Upstart in the first quarter -- stocks where certain analysts anticipate substantial upside. Palantir is successfully tapping demand for artificial intelligence (AI) with government and commercial customers, but the stock trades at a very expensive valuation. Upstart is generating attractive returns for lenders by helping them quantify credit risk with artificial intelligence, and the stock trades at a very reasonable valuation. 10 stocks we like better than Palantir Technologies › Large asset managers are required to disclose their equity holdings in quarterly Forms 13F. Investors can use those filings to track which stocks billionaires are buying. For instance, several hedge fund managers bought Palantir Technologies (NASDAQ: PLTR) and Upstart (NASDAQ: UPST) in the first quarter, as detailed below: Chris Rokos of Rokos Capital Management bought 55,809 shares of Palantir, starting a new position. Philippe Laffont of Coatue Management added 521,887 shares of Upstart, increasing his stake 150%. Ken Griffin of Citadel Advisors bought 902,486 shares of Palantir, increasing his position 204%. He also added 202,094 shares of Upstart, increasing his stake 618%. Paul Tudor Jones of Tudor Investment bought 149,191 shares of Palantir, increasing his position 573%. He also added 13,729 shares of Upstart, increasing his stake 28%. Importantly, certain Wall Street analysts see tremendous returns ahead for shareholders. Dan Ives at Wedbush Securities expects Palantir to be a $1 trillion company within three years, which implies 240% upside from its current market value of $294 billion. And Dan Dolev at Mizuho Securities recently set Upstart with a target price of $85 per share, which implies 85% upside from its current share price of $46. In its earliest days, Palantir built bespoke data analytics solutions for the U.S. intelligence community. But the company now focuses on developing modular software platforms for customers across the commercial and government sectors. Its core products (Gotham and Foundry) let customers integrate complex information and extract nuanced insights with machine learning models and analytical tools. Importantly, in 2023, Palantir introduced an adjacent Artificial Intelligence Platform (AIP) that adds support for large language models and natural language processing. In other words, AIP lets organizations infuse their data analytics workflows with generative AI. Forrester Research recently recognized Palantir as a technology leader in artificial intelligence and machine learning platforms. Palantir looked strong in the first quarter. Customer count increased 39% to 769, and the average spend per existing customer increased 24%. In turn, revenue rose 39% to $884 million, and non-GAAP (generally accepted accounting principles) earnings jumped 62% to $0.13 per diluted share. Management attributed the strong performance to demand for its AI platform. Wall Street estimates Palantir's adjusted earnings will increase at 31% annually through 2026. That makes the current valuation of 270 times earnings look outrageously expensive. Investors can look at this stock in two ways: On one hand, I think Dan Ives is right in saying Palantir will be a trillion-dollar company eventually. On the other hand, I also believe the stock is due for a sharp correction. Patient investors comfortable with volatility can reconcile those opposing views by purchasing a very small position today. And if the stock drops sharply in the coming months, they can consider buying more shares at cheaper valuations. Upstart has developed a lending platform that leans on artificial intelligence to help banks and credit unions quantify credit risk more accurately than traditional credit scores. Its business benefits from a network effect in that every data point -- whenever a borrower makes or misses a payment -- makes its machine learning models more effective. Upstart reported solid financial results in the first quarter, beating expectations on the top and bottom lines. Loan originations more than doubled, revenue increased 67% to $2.1 billion, and non-GAAP net income was $0.30 per diluted share, up from a loss of $0.31 per diluted share in the same quarter last year. Nevertheless, Upstart stock crashed after the earnings report, likely because investors are worried about the lending environment. Tariffs imposed by the Trump administration threaten to slow economic growth, perhaps to the point of recession. That would be bad news for Upstart because banks are usually more conservative about extending credit during periods of economic upheaval. However, that creates an opportunity for patient investors. Wall Street expects adjusted earnings to grow at 195% annually through 2026, which makes the current valuation of 140 times earnings look reasonable. Even if the consensus is overly optimistic, Upstart still lets lenders approve more borrowers at lower rates, which should drive demand for its platform in the long run. Importantly, Upstart-powered loans originated in the last eight quarters have beat the two-year Treasury yield by an average of 8 percentage points. That very attractive return should bring more lenders to the platform and help the company capitalize on its $3 trillion addressable market. So, while shareholders may not see 85% returns in the next year, given the uncertain economic environment, I expect the stock to perform well over the next five years. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $638,985!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $853,108!* Now, it's worth noting Stock Advisor's total average return is 978% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Trevor Jennewine has positions in Palantir Technologies. The Motley Fool has positions in and recommends Palantir Technologies and Upstart. The Motley Fool has a disclosure policy. Billionaires Are Buying 2 Artificial Intelligence (AI) Stocks That Wall Street Analysts Say Can Soar Up to 240% was originally published by The Motley Fool